Non-invasive tests are increasingly being used to improve the diagnosis and prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest update to the EASL Clinical Practice Guidelines on the use of non-invasive tests for the evaluation of liver disease severity and prognosis, focusing on the topics for which relevant evidence has been published in the last 5 years
Introduction. Nonalcoholic fatty liver disease (NAFLD) is considered as one of the most common chro...
Liver cirrhosis (LC), the end stage of many forms of chronic hepatitis of different etiologies is a ...
The rising incidence of chronic liver disease continues to be an increasing health burden. The morbi...
Non-invasive tests are increasingly being used to improve the diagnosis and prognostication of chron...
Non-invasive tests are increasingly being used to improve the diagnosis and prognostication of chron...
Currently the only accepted method (gold standard) for the diagnosis of the fibrotic stages of chron...
Background: In patients with both chronic liver diseases and dyspepsia there is the need for non-inv...
Background: In patients with both chronic liver diseases and dyspepsia there is the need for non-inv...
Background In nonalcoholic fatty liver disease (NAFLD), advanced fibrosis has been identified as ...
Owing to the high prevalence and associated complications of liver fibrosis, of any etiology, and no...
Background: Liver biopsy is the reference standard for diagnosing the extent of fibrosis in chronic ...
Abstract: Chronic liver diseases (CLDs) represent a major cause of morbidity and mortality worldwide...
The health, societal and economic consequences of chronic liver disease (CLD) are substantial and in...
Liver fibrosis should be assessed in all individuals with chronic liver disease as it predicts the r...
Introduction: With the obesity burden, non-alcoholic fatty liver disease (NAFLD) is present in 20 – ...
Introduction. Nonalcoholic fatty liver disease (NAFLD) is considered as one of the most common chro...
Liver cirrhosis (LC), the end stage of many forms of chronic hepatitis of different etiologies is a ...
The rising incidence of chronic liver disease continues to be an increasing health burden. The morbi...
Non-invasive tests are increasingly being used to improve the diagnosis and prognostication of chron...
Non-invasive tests are increasingly being used to improve the diagnosis and prognostication of chron...
Currently the only accepted method (gold standard) for the diagnosis of the fibrotic stages of chron...
Background: In patients with both chronic liver diseases and dyspepsia there is the need for non-inv...
Background: In patients with both chronic liver diseases and dyspepsia there is the need for non-inv...
Background In nonalcoholic fatty liver disease (NAFLD), advanced fibrosis has been identified as ...
Owing to the high prevalence and associated complications of liver fibrosis, of any etiology, and no...
Background: Liver biopsy is the reference standard for diagnosing the extent of fibrosis in chronic ...
Abstract: Chronic liver diseases (CLDs) represent a major cause of morbidity and mortality worldwide...
The health, societal and economic consequences of chronic liver disease (CLD) are substantial and in...
Liver fibrosis should be assessed in all individuals with chronic liver disease as it predicts the r...
Introduction: With the obesity burden, non-alcoholic fatty liver disease (NAFLD) is present in 20 – ...
Introduction. Nonalcoholic fatty liver disease (NAFLD) is considered as one of the most common chro...
Liver cirrhosis (LC), the end stage of many forms of chronic hepatitis of different etiologies is a ...
The rising incidence of chronic liver disease continues to be an increasing health burden. The morbi...